Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations), Biocon has informed that India Ratings and Research (Ind-Ra) has vide letters dated February 07, 2023 affirmed / assigned the ratings for the following instruments- Long-term issuer rating; Proposed non-convertible debentures (NCDs); Term loans-External Commercial Borrowings (ECBs); Proposed term loans; and Commercial Paper (CP).
The above information is a part of company’s filings submitted to BSE.